Location History:
- Kensington, MD (US) (1997)
- Burlingame, CA (US) (2020)
Company Filing History:
2 out of 789 
1 out of 1,217 
1 out of 1 
Years Active: 1997-2025
Title: Chi-Chao Chan: Innovator in Macular Degeneration Treatments
Introduction
Chi-Chao Chan is a prominent inventor based in Burlingame, CA (US). He has made significant contributions to the field of medical treatments, particularly in addressing macular degeneration. With a total of 3 patents to his name, Chan's work is recognized for its innovative approaches and potential impact on patient care.
Latest Patents
Chi-Chao Chan's latest patents focus on compositions and methods for treating and preventing macular degeneration. These patents disclose methods that utilize IL17 inhibitors, including IL17 receptors and fusion proteins. The fusion proteins consist of an IL17 receptor fused with a multimerization domain, along with recombinant viral vectors encoding such fusions. This innovative approach aims to provide effective treatments for individuals suffering from this debilitating condition.
Career Highlights
Throughout his career, Chan has worked with notable organizations, including Genzyme Corporation and the United States of America as represented by the Department of Health. His experience in these institutions has allowed him to develop and refine his groundbreaking ideas in the medical field.
Collaborations
Some of Chi-Chao Chan's coworkers include Samuel C. Wadsworth and Abraham Scaria. Their collaboration has contributed to the advancement of research and development in the area of macular degeneration treatments.
Conclusion
Chi-Chao Chan's innovative work in the treatment of macular degeneration showcases his dedication to improving healthcare outcomes. His patents reflect a commitment to advancing medical science and providing hope for those affected by this condition.